Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells

Journal of Cellular Biochemistry

Volumn 76, Issue 3, 2000, Pages 463-477

  Schatten, Heide ^a,b   Ripple, Maureen ^c,d,f   Balczon, Ron ^e   Weindruch, Richard ^c,d   Chakrabarti, Amitabha ^a   Taylor, Meghan ^a   Hueser, Christopher N ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Cancer Research Center   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^e UNIVERSITY OF SOUTH ALABAMA   (United States)

^f UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cell culture; Cell proliferation; Centrosomes; Cytoskeleton; Mitosis

Indexed keywords

ANDROGEN; METRIBOLONE; PACLITAXEL;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CENTROSOME; CHROMATIN; CONTROLLED STUDY; DRUG EFFECT; GENE MUTATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MICROTUBULE; MITOCHONDRION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROSTATE CANCER;

NASA DISCIPLINE DEVELOPMENTAL BIOLOGY; NASA PROGRAM FUNDAMENTAL SPACE BIOLOGY; NON-NASA CENTER;

ANDROGENS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; CENTROSOME; DIHYDROTESTOSTERONE; DNA, NEOPLASM; HUMANS; MALE; METRIBOLONE; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; NEOPLASMS, HORMONE-DEPENDENT; PACLITAXEL; PROSTATIC NEOPLASMS; TESTOSTERONE CONGENERS;

EID: 0033980684     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000301)76:3<463::AID-JCB13>3.0.CO;2-S     Document Type: Article

References (73)

1. Balczon R. 1996. The centrosome in animal cells and its functional homologs in plant and yeast cells. Int Rev Cytol 169:25-82.
2. Balczon R, West K. 1991. The identification of mammalian centrosomal antigens using human autoimmune anticentrosome antisera. Cell Motil Cytoskeleton 20:121-135.
3. Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR. 1995. Dissociation of centrosome replication events from DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 130:105-115.
4. Bester T, Schatten G. 1981. Anti-tubulin immunofluorescence microscopy of microtubules present during the pronuclear movements of sea urchin fertilization. Dev Biol 88:80-91.
5. Bhalla K. 1998. Molecular regulation of taxane-induced apoptosis. Proc Microscopy Society of America 42:1040-1041.
6. Blomberg-Wirschell M, Young A, Dictenberg J, Purohit A, Doxsey SJ. 1997. Characterization of the centrosome R2. Mol Biol Cell 8:55a.
7. Boveri T. 1914. Zur Frage der Entstehung maligner Tumoren. Jena, Germany: G. Fisher.
8. Brinkley BR, Goepfert TM. 1998. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. Cell Motil Cytoskeleton 41:281-288.
9. Bubley GJ, Balk SP. 1996. Treatment of androgen-independent prostate cancer. Oncologist 1:20-35.
10. Calarco-Gillam PC, Siebert MC, Hubble R, Mitchison T, Kirschner M. 1983. Centrosome development in early mouse embryos as defined by an autoantibody against pericentriolar material. Cell 35:621-629.
11. Chaly N, Bladon T, Setterfield G, Little JE, Kaplan JG, Brown DL. 1984. Changes in distribution of nuclear matrix antigens during the mitotic cell cycle. J Cell Biol 99:661-671.
12. Danesi R, Figg WD, Reed E, Myers CE. 1995. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol Pharmacol 47:1106-1111.
13. Evans AM, Lestingi TM, Bitran JD. 1998. Intermittent androgen suppression as a treatment for prostate cancer: a review. Oncologist 3:419-423.
14. Gobert G, Schatten H. 1998. Immunolocalization of nuclear mitotic apparatus (NuMA) protein in MCF-7 breast cancer cells. Mol Biol Cell 9:498.
15. Gueth-Hallonet C, Weber K, Osborn M. 1996. NuMA: a bipartite nuclear location signal and other functional properties of the tail domain. Exp Cell Res 225:207-218.
16. Guinan P, Shaw M, Mirochnik Y, Slobodskoy L, Ray V, Rubenstein M. 1998. Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model. Exp Clin Pharmacol 20:739-742.
17. Hart PE, Wolniak SM. 1997. Developmental regulation of centrin during spermiogenesis in Marsilea uestita. Mol Biol Cell 8:56a.
18. Joswig G, Petzelt C. 1990. The centrosomal cycle: visualization in PtK cells by a monoclonal antibody to centrosomal 32kd protein. Cell Motil Cytoskeleton 15:181-192.
19. Joswig G, Petzelt C, Werner D. 1991. Murine cDNAs coding for the centrosomal antigen centrosomin A. J Cell Sci 98(Pt1):37-43.
20. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1247-1277.
21. Kreis W, Budman DR, Fetten J, Gonzales AL, Barile B, Vinciguerra V. 1999. Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma. Ann Oncol 10:33-38.
22. Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. 1998. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA 95:2950-2955.
23. Lokeshwar BL. 1999. MMP inhibition in prostate cancer. Ann NY Acad Sci 878:271-289.
24. Lu S, Tsai SY, Tsai MJ. 1997. Regulation of androgen-dependent prostatic cancer growth: androgen reguklation of CDK2, CDK5, and CKIp16 genes. Cancer Res 57:4511-4516.
25. Mack GJ, Rees J, Sandblom O, Balczon R, Fritzler MJ, Rattner JB. 1998. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive within the centrosome. Arthritis Rheum 41:551-556.
26. Manandhar G, Joshi HC, Stearns T, Schatten G. 1997a. Centrosome reduction during mouse spermiogenesis -centriole and γ-tubulin degeneration. Mol Biol Cell 8:56a.
27. Manandhar G, Simerly C, Salisbury JL, Schatten G. 1997b. Centrosome reduction during mouse spermiogenesis -centriole and centrin degeneration. Mol Biol Cell 8:56a.
28. Narayan P. 1995. Neoplasms of the prostate gland. In: Smith's General Urology. EATanaglio and JW McAninch, editors. Norwich, CT: Appleton & Lange, p 392-433.
29. Oakley CD, Oakley BR. 1989. Identification of γ-tubulin, a new member of the tubulin superfamily encoded by mipA gene ofAspergillus nidulans. Nature 338:662-664.
30. Ohta T, Essner R, Ryu J-H, Palazzo R, Kuriyama R. 1997. Identification and characterization of CEP135, a novel centrosomal component present in a wide range of organisms. Mol Biol Cell 8:57a.
31. Petrylak DP, Macarthur RB, O'Connor J, Shelton G, Judge T, Balog J, Pfaff C, Bagliella E, Heitjan D, Fine R, Zuech N, Sawczuk I, Benson M, Olsson CA. 1999. Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer. J Clin Oncol 17:958-967.
32. Petzelt C, Joswig G, Mincheva A, Lichter P, Stammer H, Werner D. 1997a. The centrosomal protein centrosomin A and the nuclear protein centrosomin B derive from one gene by post-transcriptional processes involving RNA editing. J Cell Sci 110:2573-2578.
33. Petzelt C, Werner D, Schatten H. 1997b. In vivo-labeling of the centrosome of human primary endothelial cells by transfection with a green fluorescence protein-centrosomin-A-construct. Mol Biol Cell 8:56a.
34. Pienta KJ, Smith DC. 1997. Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer. Semin Oncol 24(suppl 15):S15-72-S15-77.
35. Pihan G, Purohit A, Knecht H, Woda B, Quesenberry P, Doxsey S. 1998. Centrosomes and cancer. Cancer Res 58:3974.
36. Rago R, Mitchen J, Wilding G. 1990. DNA fluorimetric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 191:31-34.
37. Ripple MO, Pickhardt PA, Wilding G. 1997a. Alteration in γ-glutamyl peptidase activity and messenger RNA of human prostate carcinoma cells by androgen. Cancer Res 57:2428-2433.
38. Ripple MO, Henry WF, Rago RP, Wilding G. 1997b. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 89:40-48.
39. Ripple MO, Hagopian K, Oberly TD, Schatten H, Weindruch R. 1999. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxidant Redox Signaling 1:71-81.
40. Ris H. 1985. The cytoplasmic filament system in critical point dried whole mounts and plastic-embedded sections. J Cell Biol 100:1474-1487.
41. Roth BJ, Yeap BY, Wilding G, Kasimis B, McLeod D, Loehrer PJ. 1993. Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer 72:2457-2460.
42. Rothbarth K, Petzelt C, Lu X, Todorov IT, Joswig G, Pepperkok R, Ansorge W, Werner D. 1993. cDNA-derived molecular characteristics and antibodies to a new centrosome-associated and G2/M phase-prevalent protein. J Cell Sci 104(pt 1):19-30.
43. Schatten G, Schatten H, Bestor T, Balczon R. 1982. Taxol inhibits the nuclear movements during fertilization and induces asters in unfertilized sea urchin eggs. J Cell Biol 94:455-465.
44. Schatten H. 1994. Dithiothreitol prevents membrane fusion but not centrosome or microtubule organization during the first cell cycles in sea urchins. Cell Motil Cytoskeleton 27:59-68.
45. Schatten H, Chakrabarti A. 1998. Centrosome structure and function is altered by chloral hydrate and diazepam during the first reproductive cell cycles in sea urchin eggs. Eur J Cell Biol 75:9-20.
46. Schatten H, Chakrabarti A. 1994. Centrosomes are phosphorylated in sea urchin eggs throughout the cell cycle, during artificial activation and when microtubule growth is inhibited. In: Proceedings of the fifty-second annual meeting of the Microscopy Society of America, San Francisco Press, San Francisco, p 296-297.
47. Schatten H, Schatten G, Mazia D, Balczon R, Simerly C. 1986. Behavior of centrosomes during fertilization and cell division in mouse oocytes and sea urchin eggs. Proc Natl Acad Sci USA 83:105-109.
48. Schatten H, Walter M, Mazia D, Biessmann H, Paweletz N, Coffe G, Schatten G. 1987. Centrosome detection in sea urchin eggs with a monoclonal antibody against Drosophila intermediate filament proteins: characterization of stages of the division cycle of centrosomes. Proc Natl Acad Sci USA 84:8488-8492.
49. Schatten H, Walter M, Biessmann H, Schatten G. 1988. Microtubules are required for centrosome expansion and positioning while microfilaments are required for centrosome separation in sea urchin eggs during fertilization and mitosis. Cell Motil Cytoskeleton 11:248-259.
50. Schatten H, Walter M, Biessmann H, Schatten G. 1992. Activation of maternal centrosomes in unfertilized sea urchin eggs. Cell Motil Cytoskeleton 23:61-70.
51. Schatten H, Paweletz N, Balczon R. 1993. Sulfhydryl bond formation is a prerequisite for proper cycling of centrosomes and chromosomes in mammalian tissue culture cells. In: Proceedings of the fifty-first annual meeting of the Microscopy Society of America, p 342-343.
52. Schatten H, Ripple M, Balczon R, Taylor M, Crosser M. 1998a. Centrosome proliferation in the human androgen-responsive LNCaP and the androgen-independent DU145 prostate cancer cell lines. Proc Microscopy Society of America 56:1066-1967.
53. Schatten H, Ripple M, Balczon R, Taylor M. 1998b. Centrosome abnormalities in cancer cells and tissue. ICEM14. Electron Microsc 4:243-244.
54. Schatten H, Hedrick J, Chakrabarti A. 1998c. Centrosome abnormalities in cells during aging. Scanning 20:221-222.
55. Schatten H, Hedrick J, Chakrabarti A. 1998d. The cytoskeleton of Drosophila Schneider Line-1 and Kc23 cells undergoes significant changes during long-term culture. Cell Tissue Res 294:525-535.
56. Schatten H, Hueser C, Chakrabarti A. 1999a. Centrosome structure and function is altered by experimental manipulations with formamide: implications for abnormal cell divisions during cancer. In: Microscopy and Microanalysis 5:1286-1287.
57. Schatten H, Wiedemeier A, Taylor M, Lubahn D, Greenberg NM, Besch-Williford C, Rosenfeld C, Day K, Ripple M. 1999b. Centrosome and centriole abnormalities during cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model. In: Microscopy and Microanalysis 5:1152-1153.
58. Schiff PB, Horwitz SB. 1980. Taxol stabilizes microtubules in mouse fibroblastcells. Proc Natl Acad Sci USA 77:1561-1565.
59. Smith DC, Pienta KJ. 1999. Paclitaxel in the treatment of hormone-refractory prostate cancer. Semin Oncol 26(1 suppl 2):109-111.
60. Stearns ME, Wang M. 1992. Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastasis. Cancer Res 52:3776-3781.
61. Stearns T, Kirschner M. 1994. In vitro reconstitution of centrosome assembly and function: the central role of γ-tubulin. Cell 76:623-637.
62. Stillwell E, Palacios M, Fertig N, MedsgarT, Joshi H. 1997. Mol Biol Cell 8:57a.
63. Tanagho EA, McAninch JW, editors. 1995. Smith's general urology. E Norwalk, CT: Appleton & Lange.
64. Tang TK, Tang CJ, Chao CJ, Wu CW. 1994. Nuclear mitotic apparatus protein (NuMA): spindle association, nuclear targeting and differential subcellular localization of various NuMA isoforms. J Cell Sci 107:1389-1402.
65. Thompson IM, Coltman CA, Brawley OW, Ryan A. 1995. Chemoprevention of prostate cancer. Semin Urol 13:122-129.
66. Thompson-Coffe C, Coffe G, Schatten H, Mazia D, Schatten G. 1996. Cold-treated centrosome: isolation of centrosomes from mitotic sea urchin eggs, production of an anticentrosomal antibody, and novel ultrastructural imaging. Cell Motil Cytoskeleton 33:197-207.
67. Tyrrell CJ. 1999. Controversies in the management of advanced prostate cancer. Br J Cancer 79:146-155.
68. Van Beneden E, Neyt A. 1887. Bull Acad R Belg Ser 3 14.
69. Vandre D, Davis F, Rao P, Borisy GG. 1984. Phosphoproteins are components of mitotic microtubule organizing centers. Proc Natl Acad Sci USA 81:4439-4443.
70. Wiedemeier A, Taylor M, Lubahn D, Besch-Williford C, Rosenfeld C, Day K, Schatten H. 1998. Cytoskeletal, centrosome, and nuclear abnormalities are associated with advanced stages of prostate cancer: analysis in the transgenic adenocarcinoma mouse prostate (TRAMP) model. Mol Biol Cell 9:492.
71. Wilding G. 1995. Endocrine control of prostate cancer. Cancer Surv 14:43-62.
72. Zeng C, He D, Brinkley BR. 1994. Localization on NuMA protein isoforms in the nuclear matrix of mammalian cells. Cell Motil Cytoskeleton 29:167-176.
73. Zi X, Agarwal R. 1999. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate cancer cells: implications for prostate cancer intervention. Proc Natl Acad Sci USA 96:7490-7495.